Range of qualified patients: CDEC reviewed the uncertainty in the amount of people with moderately severe to critical hemophilia B in Canada suitable for etranacogene dezaparvovec. Clinical gurus consulted by CADTH indicated that some individuals that are categorised as getting gentle or reasonable sickness might have a significant bleeding phenoty… Read More